---
title: "Bausch Health Companies Inc. (BHC.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BHC.US.md"
symbol: "BHC.US"
name: "Bausch Health Companies Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-20T10:34:50.737Z"
locales:
  - [en](https://longbridge.com/en/quote/BHC.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BHC.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BHC.US.md)
---

# Bausch Health Companies Inc. (BHC.US)

## Company Overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.bauschhealth.com](https://www.bauschhealth.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: C (0.59)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 62 / 190 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.22% |  |
| Net Profit YoY | -2920.00% |  |
| P/B Ratio | -0.96 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1986890426.08 |  |
| Revenue | 10531000000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 74.52% | A |
| Profit Margin | -11.47% | D |
| Gross Margin | 70.76% | A |
| Revenue YoY | 8.22% | C |
| Net Profit YoY | -2920.00% | E |
| Total Assets YoY | -7.28% | E |
| Net Assets YoY | -350.83% | E |
| Cash Flow Margin | -117.47% | E |
| OCF YoY | 8.22% | C |
| Turnover | 0.41 | C |
| Gearing Ratio | 104.42% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Bausch Health Companies Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "8.22%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-2920.00%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-0.96",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1986890426.08",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "10531000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "74.52%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-11.47%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "70.76%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "8.22%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-2920.00%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-7.28%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-350.83%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-117.47%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "8.22%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.41",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "104.42%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.64 | 125/190 | 24.38 | 12.63 | 6.95 |
| PB | -0.96 | 210/190 | - | - | - |
| PS (TTM) | 0.19 | 9/190 | 0.26 | 0.23 | 0.20 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 11% |
| Hold | 8 | 89% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.32 |
| Highest Target | 9.00 |
| Lowest Target | 6.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BHC.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BHC.US/norm.md)
- [Related News](https://longbridge.com/en/quote/BHC.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BHC.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**